Product Information
CALCIUM ACETATE 667 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.4387 per EA under NDC 62135019222. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Feb 5, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Calcium Acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
667 mg/1
Manufacturer
Chartwell RX LLCNDC
62135019222
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
CALCIUM ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA202420FDA Approved
2/5/2013
TE Code
AB
On Market Since
7/1/2019
Pharmacological Classes
Price Statistics
The NADAC for CALCIUM ACETATE 667 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 9.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4387 per EA |
|---|---|
| All-time high | $0.4517 (May 13, 2026) |
| All-time low | $0.3748 (Nov 20, 2024) |
| 52-week high | $0.4517 |
| 52-week low | $0.4148 |
| Median price | $0.4059 |
| Average price | $0.4088 |
| Largest weekly change | -4.6% (Jul 17, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Calcium Acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Calcium Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Blood Coagulation Factor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CALCIUM ACETATE 667 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CALCIUM ACETATE 667 MG TABLET, manufactured by Chartwell RX LLC, is $0.4387 per EA (NDC 62135019222), effective Sep 30, 2026.
How has the price of CALCIUM ACETATE 667 MG TABLET changed over time?
Over the history we have for it, the NADAC for CALCIUM ACETATE 667 MG TABLET has risen 9.4%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CALCIUM ACETATE 667 MG TABLET?
Since Apr 17, 2024, the NADAC for CALCIUM ACETATE 667 MG TABLET has ranged from a low of $0.3748 (Nov 20, 2024) to a high of $0.4517 (May 13, 2026), with a median of $0.4059 per EA.
Are there cheaper alternatives to CALCIUM ACETATE 667 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CALCIUM ACETATE 667 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CALCIUM ACETATE 667 MG TABLET?
CALCIUM ACETATE 667 MG TABLET (NDC 62135019222) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.